Multicell Techs Total Debt vs. Operating Margin
Based on Multicell Techs' profitability indicators, Multicell Techs may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Multicell Techs' ability to earn profits and add value for shareholders.
Check out Correlation Analysis.
For Multicell Techs profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Multicell Techs to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Multicell Techs utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Multicell Techs's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Multicell Techs over time as well as its relative position and ranking within its peers.
Multicell |
Multicell Techs Operating Margin vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Multicell Techs's current stock value. Our valuation model uses many indicators to compare Multicell Techs value to that of its competitors to determine the firm's financial worth. Multicell Techs is rated top company in total debt category among its peers. It also is considered to be number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Multicell Techs' earnings, one of the primary drivers of an investment's value.Multicell Total Debt vs. Competition
Multicell Techs is rated top company in total debt category among its peers. Total debt of Health Care industry is now estimated at about 49.83 Million. Multicell Techs adds roughly 36,426 in total debt claiming only tiny portion of equities under Health Care industry.
Multicell Operating Margin vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Multicell Techs |
| = | 36.43 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Multicell Techs |
| = | (0.60) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Multicell Operating Margin Comparison
Multicell Techs is currently under evaluation in operating margin category among its peers.
Multicell Techs Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Multicell Techs, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Multicell Techs will eventually generate negative long term returns. The profitability progress is the general direction of Multicell Techs' change in net profit over the period of time. It can combine multiple indicators of Multicell Techs, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island. Multicell Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Multicell Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Multicell Techs. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Multicell Techs position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Multicell Techs' important profitability drivers and their relationship over time.
Use Multicell Techs in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Multicell Techs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Multicell Techs will appreciate offsetting losses from the drop in the long position's value.Multicell Techs Pair Trading
Multicell Techs Pair Trading Analysis
The ability to find closely correlated positions to Multicell Techs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Multicell Techs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Multicell Techs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Multicell Techs to buy it.
The correlation of Multicell Techs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Multicell Techs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Multicell Techs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Multicell Techs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Multicell Techs position
In addition to having Multicell Techs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Strategy ETFs Thematic Idea Now
Strategy ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Strategy ETFs theme has 1286 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Strategy ETFs Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Multicell Pink Sheet Analysis
When running Multicell Techs' price analysis, check to measure Multicell Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Multicell Techs is operating at the current time. Most of Multicell Techs' value examination focuses on studying past and present price action to predict the probability of Multicell Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Multicell Techs' price. Additionally, you may evaluate how the addition of Multicell Techs to your portfolios can decrease your overall portfolio volatility.